Notícias 23andMe Holding Company - ME | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
23andMe Holding Company (ME)
23andMe Holding Company (ME) Notícias

23andMe Holding Company (ME)

3,11

-0,12

(-3,72%)

Fechado 23 Novembro 6:00PM

Atrasado por 15 minutos

3,22

0,11

(3,54%)

Após o horário de negociação: 8:58PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 4 - Statement of changes in beneficial ownership of securities

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

23andMe to Report Q2 FY2025 Financial Results

Form 8-K - Current report

23andMe Regains Compliance With Nasdaq Listing Requirements

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

23andMe Appoints Three New Independent Directors to Board

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições